News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Torley Helen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $43.768, valued at
$437.7k
Sold 10,000 shares
@ $43.532, valued at
$435.3k
Sold 10,000 shares
@ $43.182, valued at
$431.8k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $42.796, valued at
$428k
Sold 10,000 shares
@ $42.689, valued at
$426.9k
Sold 10,000 shares
@ $43.79, valued at
$437.9k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
|
|
| 07/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/09/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $45.469, valued at
$454.7k
Sold 10,000 shares
@ $43.259, valued at
$432.6k
Sold 10,000 shares
@ $42.727, valued at
$427.3k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
|
|
| 03/01/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Gifted 10,000 shares
@ $0 |
|
| 02/21/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 11,061 shares
@ $49.26, valued at
$544.9k
Exercised 21,010 restricted stock units
@ $0
Granted 193,360 options to buy
@ $49.26, valued at
$9.5M
Granted 67,499 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 16,469 shares
@ $48.92, valued at
$805.7k
Paid exercise price by delivering 17,266 shares
@ $48.92, valued at
$844.7k
Exercised 31,281 restricted stock units
@ $0
Exercised 32,794 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $51.258, valued at
$512.6k
Sold 10,000 shares
@ $51.357, valued at
$513.6k
Sold 10,000 shares
@ $50.4, valued at
$504k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
|
|
| 01/19/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 8,897 shares
@ $50.395, valued at
$448.4k
Sold 1,103 shares
@ $50.929, valued at
$56.2k
Sold 10,000 shares
@ $51.047, valued at
$510.5k
Sold 10,000 shares
@ $52.414, valued at
$524.1k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
|
|
| 12/15/2022 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 9,507 shares
@ $58.639, valued at
$557.5k
Sold 493 shares
@ $59.12, valued at
$29.1k
Sold 10,000 shares
@ $58.298, valued at
$583k
Sold 9,104 shares
@ $57.288, valued at
$521.5k
Sold 896 shares
@ $58.197, valued at
$52.1k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
|
|
| 11/17/2022 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 9,987 shares
@ $54.114, valued at
$540.4k
Sold 13 shares
@ $54.605, valued at
$709.9
Sold 10,000 shares
@ $53.899, valued at
$539k
Sold 10,000 shares
@ $52.149, valued at
$521.5k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
|
|
| 02/17/2022 |
4
| Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 6,892 shares
@ $34.43, valued at
$237.3k
Exercised 13,092 restricted stock units
@ $0
Granted 257,046 options to buy
@ $34.36, valued at
$8.8M
Granted 84,037 restricted stock units
@ $0 |
|
| 02/14/2022 |
4
| Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 16,598 shares
@ $34.94, valued at
$579.9k
Paid exercise price by delivering 17,266 shares
@ $34.2, valued at
$590.5k
Paid exercise price by delivering 15,125 shares
@ $33.64, valued at
$508.8k
Exercised 31,282 restricted stock units
@ $0
Exercised 32,795 restricted stock units
@ $0
Exercised 28,729 restricted stock units
@ $0 |
|
| 11/08/2021 |
4
| Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 37,775 shares
@ $39.62, valued at
$1.5M
Sold 12,225 shares
@ $40.419, valued at
$494.1k
Exercised 50,000 options to buy
@ $14.66, valued at
$733k
|
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 50,000 shares
@ $45.973, valued at
$2.3M
Exercised 50,000 options to buy
@ $14.66, valued at
$733k
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|